In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
Every year, more than 10,000 people in the UK are diagnosed with pancreatic cancer. Unfortunately, for most of those people, the disease is diagnosed too late to be cured. Less than 10% of people live five years following a diagnosis.
How clarifying the Bethesda grading system of thyroid biopsy results can help to minimise unnecessary thyroid biopsies and thyroid surgery, and a handy structured approach and explanation of the newer ultrasound classification system
In this Product Explainer, Endocrinologist Prof Susan Davis AO explains the role of topical testosterone for the treatment of hypoactive sexual desire dysfunction (HSDD) in postmenopausal women (4 mins).
Key factors when assessing a thyroid nodule are size, number and whether it is ‘hot’ or ‘cold’, says leading endocrinologist, Professor Bruce Robinson.
The importance of maintaining thyroid health during pregnancy, when to do thyroid function testing during pregnancy, and the risks of postpartum thyroiditis developing in women known to have thyroid antibodies
How can GP’s better support & manage their thyroid patients? How to achieve the optimal dose, overcoming barriers to patient compliance, and how often should we do blood tests/monitoring?
Useful management tips for Grave’s disease (GD) and Hashimotos’ thyroiditis (HT), how to manage a pregnant woman with GD or Hypothyroidism. When does a patient with HT require lifelong thyroxine replacement therapy
In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of Liraglutide 3mg in obesity management and patients who may benefit from it (5 mins).
When looking for thyroid diseases, listen to the patient as the answer is often in the history - the tests and imaging are adjuncts. Confirm your clinical suspicions with appropriate investigations.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.